These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3087219)

  • 1. Thyrotropin releasing hormone in hypovolemia: a hemodynamic evaluation in the rat.
    Sirén AL; Powell E; Feuerstein G
    Am J Physiol; 1986 Jun; 250(6 Pt 2):H1093-101. PubMed ID: 3087219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic defense response to thyrotropin-releasing hormone injected into medial preoptic nucleus in rats.
    Sirén AL; Vonhof S; Feuerstein G
    Am J Physiol; 1991 Aug; 261(2 Pt 2):R305-12. PubMed ID: 1678932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential hemodynamic effects of leukotriene D4 in anesthetized rats: evaluation by directional pulsed Doppler technique.
    Bayorh MA; Faden AI; Feuerstein G
    Prostaglandins Leukot Med; 1985 Feb; 17(2):229-41. PubMed ID: 3856895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of rat calcitonin gene-related peptide in the conscious rat.
    Sirén AL; Feuerstein G
    J Pharmacol Exp Ther; 1988 Oct; 247(1):69-78. PubMed ID: 2459371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory and cardiovascular effects of thyrotropin-releasing hormone as modified by isoflurane, enflurane, pentobarbital and ketamine.
    Schaefer CF; Brackett DJ; Biber B; Lerner MR; Holaday JW; Wilson MF; Fagraeus L
    Regul Pept; 1989 Mar; 24(3):269-82. PubMed ID: 2496439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin-releasing hormone receptor activation in the spinal cord increases blood pressure and sympathetic tone to the vasculature and the adrenals.
    Helke CJ; Phillips ET
    J Pharmacol Exp Ther; 1988 Apr; 245(1):41-6. PubMed ID: 2834544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analogue of thyrotropin-releasing hormone improves outcome after brain injury: 31P-NMR studies.
    McIntosh TK; Vink R; Faden AI
    Am J Physiol; 1988 May; 254(5 Pt 2):R785-92. PubMed ID: 3129951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and neural mechanisms of action of thyrotropin-releasing hormone in the rat.
    Sirén AL; Lake CR; Feuerstein G
    Circ Res; 1988 Jan; 62(1):139-54. PubMed ID: 2891452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin-releasing hormone increases survival in canine hemorrhagic shock.
    Sugiura A; Smith RA; Shatney CH
    J Surg Res; 1986 Jan; 40(1):63-8. PubMed ID: 3079847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nalmefene, CG3703, tirilazad, or dopamine on cerebral blood flow, oxygen delivery, and electroencephalographic activity after traumatic brain injury and hemorrhage.
    Dewitt DS; Prough DS; Uchida T; Deal DD; Vines SM
    J Neurotrauma; 1997 Dec; 14(12):931-41. PubMed ID: 9475374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-649,923: an antagonist of cardiac and vascular leukotriene D4 receptors.
    Sirén AL; Eimerl J; Feuerstein G
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):210-7. PubMed ID: 2468948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic profile of corticotropin-induced hypertension in the rat.
    Wen C; Fraser T; Li M; Whitworth JA
    J Hypertens; 1998 Feb; 16(2):187-94. PubMed ID: 9535146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic characterization of conscious and ketamine-anesthetized bile duct-ligated rats.
    Sikuler E; Buchs AE; Yaari A; Keynan A
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G161-6. PubMed ID: 1987805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inotropic support during experimental endotoxemic shock: part I. The effects of levosimendan on splanchnic perfusion.
    Cunha-Goncalves D; Perez-de-Sa V; Grins E; Dahm PL; Thörne J; Blomquist S
    Anesth Analg; 2009 Nov; 109(5):1568-75. PubMed ID: 19713249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of T-2 toxin on regional blood flow and vascular resistance in the conscious rat.
    Sirén AL; Feuerstein G
    Toxicol Appl Pharmacol; 1986 May; 83(3):438-44. PubMed ID: 3518154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of thyrotropin releasing hormone as a therapeutic intervention for endotoxemia.
    Brackett DJ; Schaefer CF; Lerner MR; Holaday JW; Fagraeus L; Wilson MF
    Regul Pept; 1990 Jul; 29(2-3):153-62. PubMed ID: 2120745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of thyrotropin releasing hormone (TRH) in circulatory shock.
    Hock CE; Lefer AM
    Peptides; 1985; 6(3):547-53. PubMed ID: 3934648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and renal effects of the protein kinase inhibitor staurosporine in conscious rats.
    Dundore RL; Brousseau AC; Habeeb PG; Pratt PF; Becker LT; Clas DM; Silver PJ; Buchholz RA
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):525-32. PubMed ID: 1280706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and respiratory effects of thyrotropin-releasing hormone and epinephrine in anaphylactic shock.
    Muelleman RL; Gatz M; Salomone JA; Herndon B; Salzman GA
    Ann Emerg Med; 1989 May; 18(5):534-41. PubMed ID: 2497665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiopulmonary effects of halothane in hypovolemic dogs.
    Pascoe PJ; Haskins SC; Ilkiw JE; Patz JD
    Am J Vet Res; 1994 Jan; 55(1):121-6. PubMed ID: 8141484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.